Stay updated on Nivolumab vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Locations section was updated with many new sites across the United States and internationally. Several previously listed sites were removed.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedPublications section wording updated to indicate that PubMed publications are auto-filled from PubMed and may not all pertain to the study, with the revision tag updated to v3.3.2. The prior wording about PubMed sourcing and revision v3.2.0 has been replaced.SummaryDifference0.1%

- Check49 days agoChange DetectedThe general government funding status notice was removed from the page, along with references to cc.nih.gov and opm.gov status updates.SummaryDifference0.2%

- Check64 days agoChange DetectedNo significant changes observed between the two screenshots; the Study Details page content appears unchanged (including overview, eligibility, design, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check93 days agoChange DetectedMajor update: new operating-status notice and v3.2.0 version; previous v3.1.0 tag removed.SummaryDifference2%

- Check100 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in Lung Cancer Clinical Trial page.